- Home
- KRNT vs SANA Comparison
KRNT vs SANA Comparison
Compare KRNT & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRNT | SANA |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | Israel | United States |
| Employees | N/A | 142 |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 747.5M | 745.8M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KRNT | SANA |
|---|---|---|
| Price | $15.83 | $2.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $19.75 | $7.80 |
| AVG Volume (30 Days) | 282.6K | ★ 4.6M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.52 | N/A |
| Revenue Next Year | $7.84 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.93 | $2.43 |
| 52 Week High | $22.06 | $6.55 |
Technical Indicators
Market Signals| Indicator | KRNT | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 35.51 |
| Support Level | $15.24 | $2.66 |
| Resistance Level | $16.55 | $3.41 |
| Average True Range (ATR) | 0.75 | 0.21 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 54.91 | 16.99 |
Price Performance
Historical ComparisonAbout KRNT Kornit Digital Ltd.
Kornit Digital Ltd is a developer and provider of digital solutions for the printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software, and value-added services that enable large-scale printing of short-run complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink, and other consumables, and services, including software subscriptions. The company geographically operates in the U.S., EMEA, Asia Pacific, and other countries. It derives maximum revenue from the U.S.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.